Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated With Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-5279
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Seladin-1 Expression Is Regulated by Promoter Methylation in Adrenal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Intratumor Heterogeneity Index of Breast Carcinomas Based on DNA Methylation Profiles

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Expression of Hypoxic Marker CA IX Is Regulated by Site-Specific DNA Methylation and Is Associated With the Histology of Gastric Cancer

American Journal of Pathology
Forensic MedicinePathology
2011English

Integrated Analysis of Gene Expression and DNA Methylation Profiles in Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2020English

New DNA Methylation Markers and Global DNA Hypomethylation Are Associated With Oral Cancer Development

Cancer Prevention Research
MedicineCancer ResearchOncology
2015English

CENPE Expression Is Associated With Its DNA Methylation Status in Esophageal Adenocarcinoma and Independently Predicts Unfavorable Overall Survival

PLoS ONE
Multidisciplinary
2019English

Differential Promoter Methylation of Kinesin Family Member 1a in Plasma Is Associated With Breast Cancer and DNA Repair Capacity

Oncology Reports
MedicineCancer ResearchOncology
2014English

A Potential Role for Immunotherapy in Thyroid Cancer by Enhancing NY-ESO-1 Cancer Antigen Expression

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2014English

Global RNA Expression and DNA Methylation Patterns in Primary Anaplastic Thyroid Cancer

Cancers
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy